Back to results
US 2026/0306408 A1Published application
Subcutaneous peptide delivery system
OwnerWilliam Demarest Johnsoninventor
Life of this patent
Estimating the term…
Abstract
A method of administering a subcutaneous peptide delivery system may include administering 0.04 mg per day via single subcutaneous cannula insertion of a subcutaneous peptide delivery system including approximately 90% peptide and an inert conveyer.
Claims19
A subcutaneous peptide delivery system, comprising:
- approximately 90% peptide;
- and
- an inert conveyer.
A method of administering a subcutaneous peptide delivery system, comprising:
- administering 0.04mg per day via single subcutaneous cannula insertion of a subcutaneous peptide delivery system comprising approximately 90% peptide and an inert conveyer.
Dependencies are inferred from the claim text.